BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND ACVR1, SKR1, 90, ENSG00000115170, Q04771, ACVRLK2, FOP, ALK2, ACTRI AND Staging
284 results:

  • 1. [Analysis of factors influencing the efficacy and prognosis of surgical treatment for primary malignant pelvic bone tumors].
    Liu WF; Hao L; Li ZY; Jin T; Sun Y; Yang YK; Li Y; Yang FJ; Yu F; Zhang Q; Niu XH
    Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):344-353. PubMed ID: 38644270
    [No Abstract]    [Full Text] [Related]  

  • 2. Optimizing PSMA scintigraphy for resource limited settings - a retrospective comparative study.
    Kolade OU; Brink A; Ayeni AO; More S; Holness J
    Cancer Imaging; 2024 Apr; 24(1):46. PubMed ID: 38556864
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Performance of cone-beam computed tomography (CBCT) in comparison to conventional computed tomography (CT) and magnetic resonance imaging (MRI) for the detection of bone invasion in oral squamous cell cancer (OSCC): a prospective study.
    Straub A; Linz C; Lapa C; Hartmann S; Kübler AC; Müller-Richter UDA; Faber J; Bley T; Brumberg J; Kertels O; Brands RC
    BMC Oral Health; 2024 Mar; 24(1):341. PubMed ID: 38493083
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [
    Li B; Ding X; Duan L; Shi J; Tang M; Zhang J; Zhao Z; Wu X; Gao Y
    Front Endocrinol (Lausanne); 2024; 15():1326858. PubMed ID: 38449842
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Detection of circulating plasma cells in peripheral blood using deep learning-based morphological analysis.
    Chen P; Zhang L; Cao X; Jin X; Chen N; Zhang L; Zhu J; Pan B; Wang B; Guo W
    Cancer; 2024 May; 130(10):1884-1893. PubMed ID: 38236717
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Comparison between whole-body magnetic resonance imaging and whole-body metaiodobenzylguanidine scintigraphy in the evaluation of primary tumor and metastases in neuroblastoma.
    Rodrigues MMC; Lederman HM; Grossman I; Castiglioni MLV; Marchetti R; Grass DC; Luisi FAV; Caran EMM
    Pediatr Blood Cancer; 2024 Mar; 71(3):e30820. PubMed ID: 38153317
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Determination of age-dependent bone marrow normocellularity.
    Wong J; Jackson R; Chen L; Song J; Pillai R; Afkhami M; Danilova O; Aoun P; Gaal KK; Kim Y
    Am J Clin Pathol; 2024 Feb; 161(2):170-176. PubMed ID: 37904278
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Management of complications of mega-implants following treatment of primary and periprosthetic fractures of the lower extremities.
    Ghanem M; Kalb A; Heyde CE; Roth A
    Sci Rep; 2023 Oct; 13(1):17594. PubMed ID: 37845299
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Factors affecting recurrence and metastasis in conjunctival melanoma.
    Çalış Karanfil F; Gündüz AK; Gündüz ÖÖ; Özalp Ateş FS
    Int Ophthalmol; 2023 Nov; 43(11):4203-4215. PubMed ID: 37639080
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Synthetic Ligament-Assisted Functional Soft-Tissue Reconstruction in Tumor-Related Proximal Femoral Replacements.
    Zhang C; He H; Tong X; Zeng H; Qiu X; Liu Q
    J Arthroplasty; 2024 Feb; 39(2):472-479. PubMed ID: 37598780
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [
    Yang L; Xu S; Cheng L; Gao C; Cao S; Chang Z; Wang K
    Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):4051-4063. PubMed ID: 37542659
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Multicenter Survival Analysis and Application of an Olfactory Neuroblastoma staging Modification Incorporating Hyams Grade.
    Choby G; Geltzeiler M; Almeida JP; Champagne PO; Chan E; Ciporen J; Chaskes MB; Fernandez-Miranda J; Gardner P; Hwang P; Ji KSY; Kalyvas A; Kong KA; McMillan R; Nayak J; O'Byrne J; Patel C; Patel Z; Peris Celda M; Pinheiro-Neto C; Sanusi O; Snyderman C; Thorp BD; Van Gompel JJ; Young SC; Zenonos G; Zwagerman NT; Wang EW
    JAMA Otolaryngol Head Neck Surg; 2023 Sep; 149(9):837-844. PubMed ID: 37535372
    [TBL] [Abstract] [Full Text] [Related]  

  • 13.
    Kersting D; Sandach P; Sraieb M; Wiesweg M; Metzenmacher M; Darwiche K; Oezkan F; Bölükbas S; Stuschke M; Umutlu L; Nader M; Hamacher R; Fendler WP; Wienker J; Eberhardt WEE; Schuler M; Herrmann K; Hautzel H
    J Nucl Med; 2023 Oct; 64(10):1540-1549. PubMed ID: 37474272
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Targeted Biopsy in Men High Risk for Prostate cancer:
    Pepe P; Pennisi M
    Clin Genitourin Cancer; 2023 Dec; 21(6):639-642. PubMed ID: 37394379
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The Role of Whole-Body Magnetic Resonance Imaging in Assessing Extrapulmonary Metastases in Osteosarcoma staging and Restaging: A Pilot Study.
    Karaarslan E; Alis D; Basar Y; Kumbasar B; Kalayci CB; Alpan B; Ozger H
    J Comput Assist Tomogr; 2023 Jul-Aug 01; 47(4):629-636. PubMed ID: 36944103
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Diagnostic Performance of PET/MRI in Breast cancer: A Systematic Review and Bayesian Bivariate Meta-analysis.
    Ruan D; Sun L
    Clin Breast Cancer; 2023 Feb; 23(2):108-124. PubMed ID: 36549970
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial.
    Mina R; Musto P; Rota-Scalabrini D; Paris L; Gamberi B; Palmas A; Aquino S; de Fabritiis P; Giuliani N; De Rosa L; Gozzetti A; Cellini C; Bertamini L; Capra A; Oddolo D; Vincelli ID; Ronconi S; Pavone V; Pescosta N; Cea M; Fioritoni F; Ballanti S; Grasso M; Zamagni E; Belotti A; Boccadoro M; Gay F
    Lancet Oncol; 2023 Jan; 24(1):64-76. PubMed ID: 36528035
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Role of
    Sopeña Sutil R; Gómez Grande A; González Díaz A; Téigel Tobar J; Cabeza Rodríguez MÁ; González Billalabeitia E; Rodríguez Antolín A
    Arch Esp Urol; 2022 Oct; 75(8):684-692. PubMed ID: 36330569
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Safely omitting bone isotope scans in a cohort of grade group 2 prostate cancer.
    Mustaffa A; Emara S
    Prostate; 2023 Jan; 83(1):128-131. PubMed ID: 36176053
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Significant CT dose reduction of 2-[
    Tang S; Hu Y; Zeng J; Li Z; Jiang Y; Li Y; Wang J; Sun H; Wu X; Zhou Y; Zhang X; Zhao Y
    Eur Radiol; 2023 Mar; 33(3):2248-2257. PubMed ID: 36166086
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 15.